Table 3 Composition of liposomal preparations with different compound I concentrations.

From: Optimization, characterization, and cytotoxicity studies of novel anti-tubercular agent-loaded liposomal vesicles

Sample

PC:CL (mg)

CPA (mg)

MPA (mg)

Amount of compound I (mg)

Chloroform (ml)

S10

165: 10

15

5

5

5

S14

160: 10

15

5

10

5

S15

155: 10

15

5

15

5

Back to article page